Irinotecan liposome、5-Fluorouracil、Leucovorin
HR-IRI-APC
Phase 3 small_molecule completed
Quick answer
Irinotecan liposome、5-Fluorouracil、Leucovorin for Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy is a Phase 3 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed